Purchase Order 75N95024P00540
Award Date 9/30/24
Potential Completion Date 9/29/25
Potential Value $25K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $34,276.75, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS), to Insphero Inc., a foreign-owned, for-profit manufacturer of 3D cell culture technologies and in vitro models. The contract is for the delivery of 3D liver microtissues composed of human primary hepatocytes, liver endothelial cells, and Kupffer cells, which will be used by NIDA's 3D Tissue Bioprinting Laboratory...
- This firm-fixed-price purchase order contract was awarded by the National Institute on Drug Abuse, a civilian agency within the U.S. Department of Health and Human Services, to Insphero Inc., a foreign-owned, for-profit manufacturer of advanced 3D cell culture technologies. The $46,829.63 contract tasks Insphero with providing 3D liver microtissues composed of human primary hepatocytes and other liver cells, which are used for drug-induced liver injury assays and toxicity testing. These...
- This is a firm fixed-price purchase order awarded to Lifenet Health, a non-profit organization and manufacturer of regenerative medicine products, by the National Institute of Mental Health (NIMH), a civilian agency. The contract has a ceiling value of $22,625.00 and a period of performance ending on July 31, 2026. Lifenet Health has previously been awarded several Blanket Purchase Agreements (BPAs) by the Department of Veterans Affairs, Defense Health Agency, and Department of the Army...
- The Food and Drug Administration has awarded a $244K delivery order to Lifenet Health, a Virginia Beach-based nonprofit manufacturer specializing in regenerative medicine products and human tissue distribution for transplantation and research. Issued on September 22, 2025, with a completion date of September 30, 2027, this firm fixed-price delivery order covers the Iontox Multi-Organ In Vitro System and represents a non-set-aside competitive award. The contract is executed under the Medical...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $91,545.00 firm fixed-price purchase order is for the delivery of assorted cell consumables. The contract has no set-aside designation. Life Technologies Corporation, a division of Thermo Fisher Scientific, has...
- This purchase order contract was awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Life Technologies Corporation for the delivery of 50 vials of human spheroid-qualified hepatocytes. As described in the original solicitation, these liver cells will support the National Institute on Drug Abuse's Antiviral Program for Pandemics by enabling the continued identification of direct-acting antivirals and development of microphysiological systems...
- This is a $3,108,022.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA) to the Lovelace Biomedical Research Institute, a non-profit preclinical contract research organization. The contract is for the characterization of a downstream gene therapeutic for the reparative treatment of severe fractures, with a period of performance from September 24, 2020 to November 23, 2021. This contract does not have a set-aside designation. Lovelace Biomedical...
- The National Institute on Drug Abuse (NIDA) awarded a $164,226.56 firm-fixed-price purchase order to Infinity Biologix LLC on September 18, 2020, for induced pluripotent stem cell (iPSC) lines for derivation study. The contract was executed as a pre-solicitation opportunity that closed on July 29, 2019, with performance to be completed by January 31, 2022. Work is to be performed in Piscataway, New Jersey, where Infinity Biologix maintains its primary operations. This purchase order was issued...
- The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a $139,030 purchase order to Lifenet Health of Virginia Beach, Virginia. Under the firm fixed price contract, Lifenet Health will provide a single organ standard system to support the agency's research efforts from August 2023 through January 2024. As the prime contractor, Lifenet Health will deliver its LIFENET HEALTH - OOC SINGLE ORGAN STANDARD SYSTEM to the...
- The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $75,000.00 firm-fixed-price purchase order to Insphero Inc., a foreign-owned for-profit manufacturer of advanced 3D cell culture products. The contract is for safety assessment studies using Insphero's human, mouse, and rat 3D liver spheroid models to evaluate drug-induced liver injury (DILI) as part of the DILIPLUS assay program. This contract...